Skip to main content
67°
Partly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Zepbound copycats remain online despite FDA ban
March 21, 2025
Tags
Business
US: News
Retail
From
CNBC.com News
Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests
March 11, 2025
Tags
Biotech and Pharmaceuticals
Science
Health & Science
From
CNBC.com News
5 things to know before the stock market opens Monday
March 10, 2025
Tags
Novo Nordisk A/S
Markets
Investing
From
CNBC.com News
Novo Nordisk shares fall 5.5% after latest trial results for its next-generation weight loss drug
March 10, 2025
Tags
Pharmaceuticals
Markets
Europe Markets
From
CNBC.com News
Amgen starts two critical late-stage trials for weight loss drug MariTide
March 05, 2025
Tags
LILLY DRN
Business News
Breaking News: Business
From
CNBC.com News
Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
March 05, 2025
Tags
Biotechnology
Novo Nordisk A/S
Health care industry
From
CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
March 04, 2025
Tags
AstraZeneca PLC
Biotech and Pharmaceuticals
Salesforce Inc
From
CNBC.com News
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
February 26, 2025
Tags
Business
US: News
Companies
From
CNBC.com News
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
February 21, 2025
Tags
LILLY DRN
Business News
Breaking News: Business
From
CNBC.com News
Cramer's Lightning Round: Sunoco is a buy
February 20, 2025
Tags
Market Outlook
Anheuser/Busch Inbev SA
Stock Picks
From
CNBC.com News
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
February 19, 2025
Tags
Biotech and Pharmaceuticals
Health & Science
Science
From
CNBC.com News
Trump's reciprocal tariffs would hit these European Union products that Americans buy the hardest
February 13, 2025
Tags
Mercedes/Benz Group AG
US: News
Europe News
From
CNBC.com News
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
February 10, 2025
Tags
Pharmaceuticals
Pfizer Inc
Health care industry
From
CNBC.com News
Hims & Hers faces scrutiny from lawmakers over 'misleading' Super Bowl ad
February 07, 2025
Tags
Health care industry
Internet
Novo Nordisk A/S
From
CNBC.com News
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
February 06, 2025
Tags
Science
Health & Science
Biotech and Pharmaceuticals
From
CNBC.com News
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
February 05, 2025
Tags
Biotech and Pharmaceuticals
Earnings
Health & Science
From
CNBC.com News
Novo Nordisk posts net profit beat as Wegovy sales jump 107% in fourth quarter
February 05, 2025
Tags
Business
LILLY DRN
Business News
From
CNBC.com News
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
February 04, 2025
Tags
Science
Health & Science
Biotech and Pharmaceuticals
From
CNBC.com News
Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir
January 31, 2025
Tags
PepsiCo Inc/
Stock Picks
U/S/ Markets
From
CNBC.com News
FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use
January 28, 2025
Tags
Science
Health & Science
Biotech and Pharmaceuticals
From
CNBC.com News
World's largest luxury group LVMH posts better than feared full-year sales
January 28, 2025
Tags
Hennessy Advisors Inc
Novo Nordisk A/S
Retail industry
From
CNBC.com News
Food-as-medicine startups hope Kennedy, if confirmed as HHS secretary, will boost their businesses
January 28, 2025
Tags
Social issues
CVS Health Corp
Nutrition
From
CNBC.com News
Novo Nordisk shares pop 10% on early-stage weight loss drug trial results
January 24, 2025
Tags
Pharmaceuticals
Biotech and Pharmaceuticals
Breaking News: Europe
From
CNBC.com News
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
January 21, 2025
Tags
Health & Science
Pfizer Inc
Biotech and Pharmaceuticals
From
CNBC.com News
'Miracle' drug innovation could see a new Wegovy launch every couple of years, Larry Summer says
January 21, 2025
Tags
World economy
World Economy
LILLY DRN
From
CNBC.com News
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
January 18, 2025
Tags
Health & Science
Amazon/com Inc
Internet
From
CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
January 17, 2025
Tags
Social issues
Business
Theravance Biopharma Inc
From
CNBC.com News
Eli Lilly CEO expects new weight loss pill to be approved next year
January 13, 2025
Tags
Health care industry
Novo Nordisk A/S
Health & Science
From
CNBC.com News
High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups
January 10, 2025
Tags
Business News
LILLY DRN
Zillow Group Inc
From
CNBC.com News
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says
January 08, 2025
Tags
Business
US: News
Social issues
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
